Beta-blocker therapy cuts all-cause mortality in STEMI

Beta-blocker therapy cuts all-cause mortality in STEMI

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with reduced all-cause mortality, according to a study published in the June issue of JACC: Cardiovascular Interventions.

Jeong Hoon Yang, M.D., from Samsung Medical Center in Seoul, South Korea, and colleagues examined the correlation of beta-blocker at discharge with clinical outcomes using data from 8,510 with STEMI undergoing primary PCI. Patients were classified into a beta-blocker group (6,873 patients) and no-beta-blocker group (1,637 patients). Propensity-score matching analysis was conducted in 1,325 patient triplets. Patients were followed for a median of 367 days for the primary outcome of all-cause death.

The researchers found that all-cause death occurred in 2.1 percent of the beta-blocker group and 3.6 percent of the no-beta-blocker group (P < 0.001). Beta-blocker therapy correlated with lower incidence of all-cause death after 2:1 propensity-score matching (2.8 versus 4.1 percent; adjusted hazard ratio, 0.46; P = 0.004). In terms of all-cause death, the correlation of beta-blocker therapy with better outcomes was consistent across subgroups, including patients with relatively low-risk profiles such as ejection fraction >40 percent or single-vessel disease.

"Our results support the current American College of Cardiology/American Heart Association guidelines, which recommend long-term beta-blocker therapy in all patients with STEMI regardless of reperfusion therapy or risk profile," the authors write.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Years of endurance exercise may raise A-fib/Flutter risk

Oct 18, 2014

(HealthDay)—Cumulative years of regular endurance exercise are associated with an increased risk for atrial fibrillation and atrial flutter, according to a study published in the Oct. 15 issue of The Am ...

Women face higher stroke rates than men

Oct 17, 2014

Supermodel and Actress Claudia Mason is helping the American Heart Association/American Stroke Association raise awareness for the world's second-leading cause of death on World Stroke Day, Oct. 29.

User comments